Tissue proteomics for cancer biomarker development - Laser microdissection and 2D-DIGE

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 9, 2008, Pages 626-634

  Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

2D DIGE; Biomarker; Cancer; Database; Laser microdissection; Medicine; Personalized; Tissue proteomics

Indexed keywords

EID: 53349167583     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.9.626     Document Type: Short Survey

References (58)

1. Cancer Statistics in Japan 2007: Foundation for Promotion of Cancer Research (FPCR), Tokyo, Japan
2. LH, S. and Wittekind, C. (2002) TNM classification of malignant tumours, 6th Ed., John Wiley & Sons, New York, USA.
3. Goya, T., Asamura, H., Yoshimura, H., Kato, H., Shimokata, K., Tsuchiya, R., Sohara, Y., Miya, T. and Miyaoka, E. (2005) Prognosis of 6644 resected non-small cell lung cancers in Japan: ajapanese lung cancer registry study. Lung Cancer 50, 227-234.
4. Herbst, R.S. (2003) Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients. Semin Oncol 30, 30-38.
5. Fukuoka, M., Yano, S., Giaccone, G., Tamura, T., Nakagawa, K., Douillard, J.Y., Nishiwaki, Y., Vansteenkiste, J., Kudoh, S., Rischin, D., Eek, R., Horai, T., Noda, K., Takata, I., Smit, E., Averbuch, S., Macleod, A., Feyereislova, A., Dong, R.P. and Baselga, J. (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J. Clin. Oncol. 21, 2237-2246.
6. Kris, M.G., Natale, R.B., Herbst, R.S., Lynch, T.J., Jr., Prager, D., Belani, C.P., Schiller, J.H., Kelly, K., Spiridonidis, H., Sandler, A., Albain, K.S., Cella, D., Wolf, M.K., Averbuch, S.D., Ochs, J.J. and Kay, A.C. (2003) Efficacy of gefitinib. an inhibitor of the epidermal growth factor receptor tyrosine kinase., in symptomatic patients with non-small cell lung cancer: a randomized trial. Jama 290, 2149-2158.
7. Inoue, A., Saijo, Y., Maemondo, M., Gomi, K., Tokue, Y., Kimura, Y., Ebina, M., Kikuchi, T., Moriya, T. and Nukiwa, T. (2003) Severe acute interstitial pneumonia and gefitinib. Lancet 361, 137-139.
8. Takano, T., Ohe, Y., Sakamoto, H., Tsuta, K., Matsuno, Y., Tateishi, U., Nokihara, H., Yamamoto, N., Sekine, I., Kunitoh, H., Shibata, T., Sakiyama, T., Yoshida, T. and Tamura, T. (2005) Mutations of the epidermal growth factor receptor strongly predict gefitinib sensitivity in Japanese patients with recurrent non-small-cell lung cancer. J. Clin. Oncol. 23, 6829-6837.
9. Tarro, G., Perna, A. and Esposito, C. (2005) Early diagnosis of lung cancer by detection of tumor liberated protein. J. Cell Physiol. 203, 1-5.
10. Chen, G., Gharib, T.G., Huang, C.C., Taylor, J.M., Misek, D.E., Kardia, S.L., Giordano, T.J., lannettoni, M.D., Orringer, M.B., Hanash, S.M. and Beer, D.G. (2002) Discordant protein and mRIMA expression in lung adenocarcinomas. Mol. Cell Proteomics. 1, 304-313.
11. Fukui, T., Ohe, Y., Tsuta, K., Furuta, K., Sakamoto, H., Takano, T., Nokihara, H., Yamamoto, N., Sekine, I., Kunitoh, H., Asamura, H., Tsuchida, T., Kaneko, M., Kusumoto, M., Yamamoto, S., Yoshida, T. and Tamura, T. (2008) Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer. Clin. Cancer Res. 14, 4751-4757.
12. Suehara, Y., Kondo, T., Seki, K., Shibata, T., Fujii, K., Gotoh, M., Hasegawa, T., Shimada, Y., Sasako, M., Shimoda, T., Kurosawa, H., Beppu, Y., Kawai, A. and Hirohashi, S. (2008) Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin. Cancer Res. 14, 1707-1717.
13. Nilsson, B., Sjolund, K., Kindblom, L.G., Meis-Kindblom, J.M., Bumming, P., Nilsson, O., Andersson, J. and Ahlman, H. (2007) Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br. J. Cancer 96, 1656-1658.
14. Yokoo, H., Kondo, T., Okano, T., Nakanishi, K., Sakamoto, M., Kosuge, T., Todo, S. and Hirohashi, S. (2007) Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci. 98, 665-673.
15. Orimo, T. (2008) APC-binding protein EB1 as a prognostic bio-marker of hepatocellular carcinoma revealed by proteomics. Hepatology in press.
16. Lee, H.C., Kim, M. and Wands, J.R. (2006) Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci. 11, 1901-1915.
17. Fujii, K., Kondo, T., Yokoo, H., Yamada, T., Iwatsuki, K. and Hirohashi, S. (205) Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5, 1411-1422.
18. Wang, Y., Zhou, X., Zhu, H., Liu, S., Zhou, C., Zhang, G., Xue, L., Lu, N., Quan, L., Bai, J., Zhan, Q. and Xu, N. (2005) Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 24, 6637-6645.
19. Okano, T., Kondo, T., Fujii, K., Nishimura, T., Takano, T., Ohe, Y., Tsuta, K., Matsuno, Y., Gemma, A., Kato, H., Kudoh, S. and Hirohashi, S. (2007) Proteomic signature corresponding to the response to gefitinib (Iressa. ZD1839). an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and mutation in EGFR in lung adenocarcinoma. Clin. Cancer Res. 13, 799-805.
20. Hatakeyama, H., Kondo, T., Fujii, K., Nakanishi, Y., Kato, H., Fukuda, S. and Hirohashi, S. (2006) Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 6, 6300-6316.
21. Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, K., Nishimura, H., Gemma, A., Kudoh, S. and Hirohashi, S. (2006) Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE). Proteomics 6, 3938-3948.
22. Kakisaka, T., Kondo, T., Okano, T., Fujii, K., Honda, K., Endo, M., Tsuchida, A., Aoki, T., Itoi, T., Moriyasu, F., Yamada, T., Kato, H., Nishimura, T., Todo, S. and Hirohashi, S. (2007) Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glyco-protein in pancreatic cancer. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1, 257-267.
23. Krew, M. (1975) Alpha-fetoprotein. Butterworths, London, UK.
24. Liebman, H.A., Furie, B.C., Tong, M.J., Blanchard, R.A., Lo, K.J., Lee, S.D., Coleman, M.S. and Furie, B. (1984) Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 310, 1427-1431.
25. Capurro, M., Wanless, I.R., Sherman, M., Deboer, G., Shi, W., Miyoshi, E. and Filmus, J. (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89-97.
26. Saito, S., Ojima, H., Ichikawa, H., Hirohashi, S. and Kondo, T. (2008) Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Science in press.
27. Capurro, M.I., Xiang, Y.Y., Lobe, C. and Filmus, J. (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65, 6245-6254.
28. Zhang, C., Li, Z., Cheng, Y., Jia, F., Li, R., Wu, M., Li, K. and Wei, L. (2007) CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Clin. Cancer Res. 13, 944-952.
29. Lee, J.S. and Thorgeirsson, S.S. (2002) Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 35, 1134-1143.
30. Yokoo, H., Kondo, T., Fujii, K., Yamada, T., Todo, S. and Hirohashi, S. (2004) Proteomic signature corresponding to alpha fetoprotein expression in liver cancer celIs. Hepatology 40, 609-617.
31. Mroczko, B., Kozlowski, M., Groblewska, M., Lukaszewicz, M., Niklinski, J., Jelski, W., Laudanski, J., Chyczewski, L. and Szmitkowski, M. (2008) The diagnostic value of the measurement of matrix metalloproteinase 9, (MMP-9)., squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clin. Chim. Acta. 389, 61-66.
32. Chignard, N., Shang, S., Wang, H., Marrero, J., Brechot, C., Hanash, S. and Beretta, L. (2006) Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 130, 2010-2022.
33. Hober, S. and Uhlen, M. (2008) Human protein atlas and the use of microarray technologies. Curr. Opin. Biotechnol. 19, 30-35.
34. Emmert-Buck, M.R., Bonner, R.F., Smith, P.D., Chuaqui, R.F., Zhuang, Z., Goldstein, S.R., Weiss, R.A. and Liotta, L.A. (1996) Laser capture microdissection. Science 274, 998-1001.
35. Banks, R.E., Dunn, M.J., Forbes, M.A., Stanley, A., Pappin, D., Naven, T., Gough, M., Harnden, P. and Selby, P.J. (1999) The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings. Electrophoresis 20, 689-700.
36. Ornstein, D.K., Gillespie, J.W., Paweletz, C.P., Duray, P.H., Herring, J., Vocke, CD., Topalian, S.L., Bostwick, D.G., Linehan, W.M., Petricoin, E.F., 3rd. and Emmert-Buck, M.R. (2000) Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235-2242.
37. Emmert-Buck, M.R., Gillespie, J.W., Paweletz, C.P., Ornstein, D.K., Basrur, V., Appella, E., Wang, Q.H., Huang, J., Hu, N., Taylor, P. and Petricoin, E.F., 3rd. (2000) An approach to proteomic analysis of human tumors. Mol. Carcinog 27, 158-165.
38. Lawrie, L.C., Curran, S., McLeod, H.L., Fothergill, J.E. and Murray, G.I. (2001) Application of laser capture micro-dissection and proteomics in colon cancer. Mol. Pathol. 54, 253-258.
39. Wright, G.L., Cazares, L.H. and Leung, S.M. (1999) Protein chip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis. 2, 264-276.
40. Von Eggeling, F., Davies, H., Lomas, L., Fiedler, W., Junker, K., Claussen, U. and Ernst, G. (2000) Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 29, 1066-1070.
41. Simone, NL., Remaley, AT., Charboneau, L., Petricoin, EF., 3rd., Glickman, JW., Emmert-Buck, MR., Fleisher, TA. and Liotta, LA. (2000) Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol. 156, 445-452.
42. Natkunam, Y., Rouse, R.V., Zhu, S., Fisher, C. and van, De Rijn M (2000) Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am. J. Pathol. 156, 21-27.
43. Ornstein, D.K., Englert, C., Gillespie, J.W., Paweletz, C.P., Linehan, W.M., Emmert-Buck, M.R. and Petricoin, E.F., 3rd. (2000) Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin. Cancer Res. 6, 353-356.
44. Paweletz, C.P., Ornstein, D.K., Roth, M.J., Bichsel, V.E., Gillespie, J.W., Calvert, V.S., Vocke, C.D., Hewitt, S.M., Duray, P.H., Herring, J., Wang, Q.H., Hu, N., Linehan, W.M., Taylor, P.R., Liotta, L.A., Emmert-Buck, M.R. and Petricoin, E.F., 3rd. (2000) Lossofannexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60, 6293-6297.
45. Craven, R.A., Totty, N., Harnden, P., Selby, P.J. and Banks, R.E. (2002) Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am. J. Pathol. 160, 815-822.
46. Shekouh, A.R., Thompson, C.C., Prime, W., Campbell, F., Hamlett, J., Herrington, C.S., Lemoine, N.R., Crnogorac-Jurcevic, T., Buechler, M.W., Friess, H., Neoptolemos, J.P., Pennington, S.R. and Costello, E. (2003) Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 3, 1988-2001.
47. Unlu, M., Morgan, M.E. and Minden, J.S. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077.
48. Kondo, T., Seike, M., Mori, Y., Fujii, K., Yamada, T. and Hirohashi, S. (2003) Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 3, 1 758-1 766.
49. Seike, M., Kondo, T., Fujii, K., Okano, T., Yamada, T., Matsuno, Y., Gemma, A., Kudoh, S. and Hirohashi, S. (2005) Proteomic signatures for histological types of lung cancer. Proteomics 5, 2939-2948.
50. Sitek, B., Luttges, J., Marcus, K., Kloppel, G., Schmiegel, W., Meyer, H.E., Hahn, S.A. and Stuhler, K. (2005) Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 5, 2665-2679.
51. Greengauz-Roberts, O., Stoppler, H., Nomura, S., Yamaguchi, H., Goldenring, J.R., Podolsky, R.H., Lee, J.R. and Dynan, W.S. (2005) Saturation labeling with cysteine-reactive cya-nine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics 5, 1 746-1757.
52. Wilson, K.E., Marouga, R., Prime, J.E., Pashby, D.P., Orange, P.R., Crosier, S., Keith, A.B., Lathe, R., Mullins, J., Estibeiro, P., Bergling, H., Hawkins, E. and Morris, CM. (2005) Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 5, 3851-3858.
53. Sitek, B., Potthoff, S., Schulenborg, T., Stegbauer, J., Vinke, T., Rump, L.C., Meyer, H.E., Vonend, O. and Stuhler, K. (2006) Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling. Proteomics 6, 4337-4345.
54. Kondo, T. and Hirohashi, S. (2006) Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc. 1, 2940-2956.
55. Fujii, K., Kondo, T., Yokoo, H., Okano, T., Yamada, M., Yamada, T., Iwatsuki, K. and Hirohashi, S. (2006) Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. Proteomics 6, 1640-53.
56. Young, DA., Voris, B.P., Maytin, E.V. and Colbert, R.A. (1983) Very-high-resolution two-dimensional electrophoretic separation of proteins on giant gels. Methods Enzymol 91, 190-214.
57. Klose, J., Nock, C., Herrmann, M., Stuhler, K., Marcus, K., Bluggel, M., Krause, E., Schalkwyk, L.C., Rastan, S., Brown, S.D., Bussow, K., Himmelbauer, H. and Lehrach, H. (2002) Genetic analysis of the mouse brain proteome. Nat. Genet. 30, 385-393.
58. Oguri, T., Takahata, I., Katsuta, K., Nomura, E., Hidaka, M. and Inagaki, N. (2002) Proteome analysis of rat hippo-campal neurons by multiple large gel two-dimensional electrophoresis. Proteomics 2, 666-672.